Compounds, compound generation procedures, pharmaceutical ingredients, use of compounds, and treatments for mental and / or sleep disorders

摘要

The present invention relates to the new and invented benzimer derivatives with effective activity, which are very close to the MT1 and MT2 receptors of melamine, and have a low relationship with CYP450 compounds, especially CYP1A2 enzymes. It also describes the new and creative synthetic pathways of these compounds, the pharmaceutical ingredients that contain them, and the use of these compounds in the treatment of patients with mental disorders and / or sleep disorders (especially depression) associated with these receptors. Anxiety and circulatory disorders,In addition to the member's production process.